ACCELEVIR DIAGNOSTICS LLC — Department of Health and Human Services SBIR Phase II: 78

ACCELEVIR DIAGNOSTICS LLC — SBIR Phase II award from Department of Health and Human Services.

Amount
$2,000,000
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
78
Solicitation
75N93022R00025
NAICS
Place of performance
MD
Period

Description

The objective of this program is to develop and commercialize sequence-based HIV reservoir assays for clinical HIV cure interventions. The assay should be designed as an analytical tool to monitor the size of the replication-competent HIV reservoir in clinical research and in prospective clinical trials. An additional goal of the program is to develop secondary assays that are not tissue culture-based and discriminate between actively transcribed and latent full-length proviruses. This contract is to develop and validate version 2 of the IPDA for use across major HIV-1 Group M subtypes and recombinants.